These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17391862)

  • 1. Restoration of cellular energetic balance with L-carnitine in the neuro-bioenergetic approach for cancer prevention and treatment.
    Hoang BX; Graeme Shaw D; Pham P; Levine S
    Med Hypotheses; 2007; 69(2):262-72. PubMed ID: 17391862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of carnitine esters in brain neuropathology.
    Virmani A; Binienda Z
    Mol Aspects Med; 2004; 25(5-6):533-49. PubMed ID: 15363640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system.
    Peluso G; Nicolai R; Reda E; Benatti P; Barbarisi A; Calvani M
    J Cell Physiol; 2000 Mar; 182(3):339-50. PubMed ID: 10653600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in carnitine in chronic uremia.
    Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
    J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose avidity of carcinomas.
    Ortega AD; Sánchez-Aragó M; Giner-Sánchez D; Sánchez-Cenizo L; Willers I; Cuezva JM
    Cancer Lett; 2009 Apr; 276(2):125-35. PubMed ID: 18790562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimyopathic effects of carnitine and nicotine.
    Laviano A; Meguid MM; Guijarro A; Muscaritoli M; Cascino A; Preziosa I; Molfino A; Rossi Fanelli F
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):442-8. PubMed ID: 16778574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuro-bioenergetic concepts in cancer prevention and treatment.
    Hoang BX; Graeme Shaw D; Pham P; Levine SA
    Med Hypotheses; 2007; 68(4):832-43. PubMed ID: 17069985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Carnitine in the treatment of fatigue in adult celiac disease patients: a pilot study.
    Ciacci C; Peluso G; Iannoni E; Siniscalchi M; Iovino P; Rispo A; Tortora R; Bucci C; Zingone F; Margarucci S; Calvani M
    Dig Liver Dis; 2007 Oct; 39(10):922-8. PubMed ID: 17693145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for mitochondria-targeting strategies in cancer bioenergetic therapies.
    Jose C; Rossignol R
    Int J Biochem Cell Biol; 2013 Jan; 45(1):123-9. PubMed ID: 22776740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial bioenergetic background confers a survival advantage to HepG2 cells in response to chemotherapy.
    Loiseau D; Morvan D; Chevrollier A; Demidem A; Douay O; Reynier P; Stepien G
    Mol Carcinog; 2009 Aug; 48(8):733-41. PubMed ID: 19347860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
    Silva-Adaya D; Pérez-De La Cruz V; Herrera-Mundo MN; Mendoza-Macedo K; Villeda-Hernández J; Binienda Z; Ali SF; Santamaría A
    J Neurochem; 2008 May; 105(3):677-89. PubMed ID: 18194214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetyl-L-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain.
    Alves E; Binienda Z; Carvalho F; Alves CJ; Fernandes E; de Lourdes Bastos M; Tavares MA; Summavielle T
    Neuroscience; 2009 Jan; 158(2):514-23. PubMed ID: 19015003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria in cancer cells: what is so special about them?
    Gogvadze V; Orrenius S; Zhivotovsky B
    Trends Cell Biol; 2008 Apr; 18(4):165-73. PubMed ID: 18296052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiological functions of carnitine and carnitine transporters in the central nervous system].
    Inazu M; Matsumiya T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Jun; 28(3):113-20. PubMed ID: 18646596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting mitochondrial permeability in cancer drug development.
    Berridge MV; Herst PM; Lawen A
    Mol Nutr Food Res; 2009 Jan; 53(1):76-86. PubMed ID: 19035550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism.
    Bagetta V; Barone I; Ghiglieri V; Di Filippo M; Sgobio C; Bernardi G; Calabresi P; Picconi B
    Neuropharmacology; 2008 Aug; 55(2):223-9. PubMed ID: 18590920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondria in cancer: not just innocent bystanders.
    Frezza C; Gottlieb E
    Semin Cancer Biol; 2009 Feb; 19(1):4-11. PubMed ID: 19101633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aging eye and the role of L-carnitine and its derivatives.
    Pescosolido N; Imperatrice B; Karavitis P
    Drugs R D; 2008; 9 Suppl 1():3-14. PubMed ID: 19105587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular ATP increases L-carnitine transport and content in C2C12 cells.
    Rigault C; Bernard A; Georges B; Kandel A; Pfützner E; Le Borgne F; Demarquoy J
    Pharmacology; 2008; 81(3):246-50. PubMed ID: 18230920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria as targets for cancer chemotherapy.
    Gogvadze V; Orrenius S; Zhivotovsky B
    Semin Cancer Biol; 2009 Feb; 19(1):57-66. PubMed ID: 19101636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.